Capecitabine Market Share

Market Share of Capecitabine Industry

The global capecitabine market is moderately competitive and consists of several major players. Few of the prominent players currently dominating the market are applying various strategies like acquiring the products or other companies to consolidate their market positions across the globe and while others are launching generic products. For example, in April 2019, Armas Pharmaceuticals, Inc launched a generic version of Roches's Xeloda, a capecitabine product. Such product launches are expected to propel the market growth. Some of the companies which are currently dominating the market are Cipla Inc., Teva Pharmaceuticals USA Inc, F. Hoffmann-La Roche AG (Genentech, Inc.), Mylan N.V., and Hikma Pharmaceuticals PLC.

Capecitabine Market Leaders

1. Teva Pharmaceuticals, Inc

2. F. Hoffmann-La Roche AG (Genentech, Inc.)

3. Mylan N.V.

4. Hikma Pharmaceuticals PLC

5. Cipla Inc.

*Disclaimer: Major Players sorted in no particular order